The importance of water exchange rates in the design of responsive agents for MRI

Current Opinion in Chemical Biology

Volumn 17, Issue 2, 2013, Pages 167-174

  Sherry, A Dean ^a,b   Wu, Yunkou ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LANTHANIDE; WATER;

HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; REVIEW; WATER TRANSPORT;

CONTRAST MEDIA; COORDINATION COMPLEXES; KINETICS; LANTHANOID SERIES ELEMENTS; MAGNETIC RESONANCE IMAGING; WATER;

EID: 84876736794     PISSN: 13675931     EISSN: 18790402     Source Type: Journal    
DOI: 10.1016/j.cbpa.2012.12.012     Document Type: Review

References (38)

1. Moats R.A., Fraser S.E., Meade T.J. A " smart" magnetic resonance imaging agent that reports on specific enzymatic activity. Angew Chem Int Ed Engl 1997, 36:726-728.
2. Caravan P. Strategies for increasing the sensitivity of gadolinium based MRI contrast agents. Chem Soc Rev 2006, 35:512-523.
3. - related to NMR imaging. Inorg Chem 1993, 32:3844-3850.
4. - in aqueous solution: a variable-pressure-temperature and -magnetic field oxygen-17 NMR study. Magn Reson Chem 1993, 31:1011-1020.
5. 3+ complexes of DTPA-amide and -ester conjugates. Magn Reson Med 1988, 8:191-199.
6. The Chemistry of Contrast Agents in Medical Magnetic Resonance Imaging 2001, Wiley, Chichester. A.E. Merbach, T. Tóth (Eds.).
7. Caravan P. Protein-targeted gadolinium-based Magnetic Resonance Imaging (MRI) contrast agents: design and mechanism of action. Acc Chem Res 2009, 42:851-862.
8. Caravan P., Ellison J.J., McMurry T.J., Lauffer R.B. Gadolinium(III) chelates as MRI contrast agents: structure, dynamics, and applications. Chem Rev 1999, 99:2293-2352.
9. Caravan P., Zhang Z. Structure-relaxivity relationships among targeted MR contrast agents. Eur J Inorg Chem 2012, 1916-1923.
10. - for use as an MRI contrast agent. Inorg Chem 2007, 46:4796-4798.
11. Thompson M.K., Botta M., Nicolle G., Helm L., Aime S., Merbach A.E., Raymond K.N. A highly stable gadolinium complex with a fast, associative mechanism of water exchange. J Am Chem Soc 2003, 125:14274-14275.
12. Werner E.J., Avedano S., Botta M., Hay B.P., Moore E.G., Aime S., Raymond K.N. Highly soluble Tris-hydroxypyridonate Gd(III) complexes with increased hydration number, fast water exchange. Slow electronic relaxation, and high relaxivity. J Am Chem Soc 2007, 129:1870-1871.
13. Werner E.J., Kozhukh J., Botta M., Moore E.G., Avedano S., Aime S., Raymond K.N. 1,2-Hydroxypyridonate/terephthalamide complexes of gadolinium(III): synthesis, stability, relaxivity, and water exchange properties. Inorg Chem 2008, 48:277-286.
14. Xu J., Churchill D.G., Botta M., Raymond K.N. Gadolinium(III) 1,2-hydroxypyridonate-based complexes: toward MRI contrast agents of high relaxivity. Inorg Chem 2004, 43:5492-5494.
15. -: a paramagnetic contrast agent designed for improved applications in magnetic resonance imaging. J Med Chem 2000, 43:4017-4024.
16. -: a new structural entry for an improved generation of MRI contrast agents. Inorg Chem 2004, 43:7588-7590.
17. Gianolio E., Giovenzana G.B., Longo D., Longo I., Menegotto I., Aime S. Relaxometric and modelling studies of the binding of a lipophilic Gd-AAZTA complex to fatted and defatted human serum albumin. Chemistry 2007, 13:5785-5797.
18. Overoye-Chan K., Koerner S., Looby R.J., Kolodziej A.F., Zech S.G., Deng Q., Chasse J.M., McMurry T.J., Caravan P EP-2104R: a fibrin-specific gadolinium-Based MRI contrast agent for detection of thrombus. J Am Chem Soc 2008, 130:6025-6039.
19. Vymazal J., Spuentrup E., Cardenas-Molina G., Wiethoff A.J., Hartmann M.G., Caravan P., Parsons E.C. Thrombus imaging with fibrin-specific gadolinium-based MR contrast agent EP-2104R: results of a phase II clinical study of feasibility. Invest Radiol 2009, 44:697-704.
20. Nair S.A., Kolodziej A.F., Bhole G., Greenfield M.T., McMurry T.J., Caravan P. Monovalent and bivalent fibrin-specific MRI contrast agents for detection of thrombus. Angew Chem Int Ed Engl 2008, 47:4918-4921.
21. Zhang Z., Kolodziej A.F., Greenfield M.T., Caravan P. Heteroditopic binding of magnetic resonance contrast agents for increased relaxivity. Angew Chem Int Ed Engl 2011, 50:2621-2624.
22. Uppal R., Catana C., Ay I., Benner T., Sorensen A.G., Caravan P. Bimodal thrombus imaging: simultaneous PET/MR imaging with a fibrin-targeted dual PET/MR probe-feasibility study in rat model. Radiology 2011, 258:812-820.
23. Caravan P., Das B., Dumas S., Epstein F.H., Helm P.A., Jacques V., Koerner S., Kolodziej A., Shen L., Sun W.C., et al. Collagen-targeted MRI contrast agent for molecular imaging of fibrosis. Angew Chem Int Ed Engl 2007, 46:8171-8173.
24. Caravan P., Das B., Deng Q., Dumas S., Jacques V., Koerner S.K., Kolodziej A., Looby R.J., Sun W.C., Zhang Z A lysine walk to high relaxivity collagen-targeted MRI contrast agents. Chem Commun 2009, 45:430-432.
25. Esqueda A.C., Lopez J.A., Andreu-de-Riquer G., Alvarado-Monzon J.C., Ratnakar J., Lubag A.J., Sherry A.D., De Leon-Rodriguez L.M. A new gadolinium-based MRI zinc sensor. J Am Chem Soc 2009, 131:11387-11391.
26. 2+-responsive contrast agent. Proc Natl Acad Sci USA 2011, 108:18400-18405.
27. van Zijl P.C., Yadav N.N. Chemical exchange saturation transfer (CEST): what is in a name and what isn't?. Magn Reson Med 2011, 65:927-948.
28. Zhang S., Winter P., Wu K., Sherry A.D. A novel europium(III)-based MRI contrast agent. J Am Chem Soc 2001, 123:1517-1518.
29. Woessner D.E., Zhang S., Merritt M.E., Sherry A.D. Numerical solution of the Bloch equations provides insights into the optimum design of PARACEST agents for MRI. Magn Reson Med 2005, 53:790-799.
30. Dixon W.T., Ren J., Lubag A.J., Ratnakar J., Vinogradov E., Hancu I., Lenkinski R.E., Sherry A.D. A concentration-independent method to measure exchange rates in PARACEST agents. Magn Reson Med 2010, 63:625-632.
31. Viswanathan S., Kovacs Z., Green K.N., Ratnakar S.J., Sherry A.D. Alternatives to gadolinium-based metal chelates for magnetic resonance imaging. Chem Rev 2010, 110:2960-3018.
32. Mani T., Tircso G., Togao O., Zhao P., Soesbe T.C., Takahashi M., Sherry A.D. Modulation of water exchange in Eu(III) DOTA-tetraamide complexes: considerations for in vivo imaging of PARACEST agents. Contrast Media Mol Imaging 2009, 4:183-191.
33. 2 by chemical exchange rather than relaxation. Magn Reson Med 2011, 66:1697-1703.
34. 17 in aqueous solutions of paramagnetic cations and lifetime of water molecules in first coordination sphere. J Chem Phys 1962, 37:307-321.
35. Zhang S.R., Sherry A.D. Physical characteristics of lanthanide complexes that act as magnetization transfer (MT) contrast agents. J Solid State Chem 2003, 171:38-43.
36. Soesbe T., Wu Y., Sherry A. Advantages of paramagnetic chemical exchange saturation transfer (CEST) complexes having slow-to-intermediate water exchange properties as responsive MRI agents NMR in Biomedicine 2012, http://dx.doi.org/10.1002/nbm.2874.
37. 3+ complexes of interest in magnetic resonance imaging: an integrated and theoretically self-consistent approach. J Am Chem Soc 1996, 118:9333-9346.
38. Green K.N., Viswanathan S., Rojas-Quijano F.A., Kovacs Z., Sherry A.D. Europium(III) DOTA-derivatives having ketone donor pendant arms display dramatically slower water exchange. Inorg Chem 2011, 50:1648-1655.